Laboratorios Farmaceutocos Rovi SA (ROVI) EUR0.06

Sell:€50.50Buy:€51.40€0.05 (0.10%)

Prices delayed by at least 15 minutes
Sell:€50.50
Buy:€51.40
Change:€0.05 (0.10%)
Deal now
Prices delayed by at least 15 minutes
Sell:€50.50
Buy:€51.40
Change:€0.05 (0.10%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.

Key people

Juan Lopez-Belmonte Encina
Executive Chairman of the Board, Chief Executive Officer
Javier Lopez-Belmonte Encina
First Executive Vice Chairman of the Board, Chief Financial Officer, General Manager of Industrial Operations
Ivan Jorge Lopez-Belmonte Encina
Second Executive Vice Chairman of the Board, Chief Commercial and Development Officer
Marta Campos
Director - Finance and Investor Relations
Mercedes Benitez Del Castillo Sanchez
Director - Legal
Maria Rosario Perucha Perez
Director - Marketing
Francisco Javier Angulo Garcia
Director - Human Resources
Pedro Carretero Trillo
Director - Hospital Network
Miguel Angel Castillo San Roman
Director - International and Business Development
Marta Garcia Molynuex
Director - Records
Marcos Pena Pinto
Lead External Independent Director
Marina Del Corral Tellez
Proprietary Director
Fatima Banez Garcia
Independent Director
Teresa Corzo Santamaria
Independent Director
Click to see more

Key facts

  • EPIC
    ROVI
  • Location
    Spain
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    ES0157261019
  • Market cap
    €2.62bn
  • Employees
    2,179
  • Shares in issue
    51.24m
  • Exchange
    Mercado Continuo Espana
  • Index
    IBEX 35 Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.